Sciclone Pharma (SCLN) Reports Q3 EPS of $0.26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Income from operations: 10.45M
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Income from operations: 10.45M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Sciclone Pharma (NASDAQ: SCLN) reported Q3 EPS of $0.2, versus $0.17 reported last year. Revenue for the quarter came in at $42.9 million, versus $34.3 million reported last year.
For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- UBS Reiterates Buy Rating on Pepsico (PEP) on Q3 Beat
- Alibaba ADR climbs on analyst upgrades, AI momentum
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
